Common Contracts

118 similar Common Share Purchase Warrant contracts by Medicus Pharma Ltd., Aptose Biosciences Inc., Damon Inc., others

COMMON SHARE PURCHASE WARRANT MEDICUS PHARMA LTD.
Common Share Purchase Warrant • June 2nd, 2025 • Medicus Pharma Ltd. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 3, 2030 (the "Termination Date") but not thereafter, to subscribe for and purchase from Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), up to 2,260,000 common shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warr

COMMON SHARE PURCHASE WARRANT MEDICUS PHARMA LTD.
Common Share Purchase Warrant • May 27th, 2025 • Medicus Pharma Ltd. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), up to ______ common shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, s

Common SHARE PURCHASE WARRANT
Common Share Purchase Warrant • March 25th, 2025 • Damon Inc. • Motorcycles, bicycles & parts • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date listed above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 21, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Damon Inc., a British Columbia corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT SOLARBANK CORPORATION
Common Share Purchase Warrant • March 21st, 2025 • SolarBank Corp • Electric & other services combined • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 24, 2030 (the “Termination Date”), but not after the Termination Date, to subscribe for and purchase from SolarBank Corporation, a company incorporated under the laws of the province of Ontario (the “Company”), up to [______] common shares (the “Common Shares”) of the Company (as subject to adjustment hereunder, the “Warrant Shares”), provided, however, in the event that the Warrant is held by directors, officers or other affiliates of the Company and the Termination Date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in the Common Shares, such officers,

Common SHARE PURCHASE WARRANT DAMON INC.
Common Share Purchase Warrant • March 18th, 2025 • Damon Inc. • Motorcycles, bicycles & parts • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date listed above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Damon Inc., a British Columbia corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT MEDICUS PHARMA LTD.
Common Share Purchase Warrant • March 11th, 2025 • Medicus Pharma Ltd. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on March 10, 2030 (the "Termination Date") but not thereafter, to subscribe for and purchase from Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), up to 1,490,000 common shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Wa

COMMON SHARE PURCHASE WARRANT MEDICUS PHARMA LTD.
Common Share Purchase Warrant • February 14th, 2025 • Medicus Pharma Ltd. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), up to ______ common shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, s

FORM OF COMMON SHARE PURCHASE WARRANT LI-CYCLE HOLDINGS CORP.
Common Share Purchase Warrant • January 16th, 2025 • Li-Cycle Holdings Corp. • Hazardous waste management

This COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [•], 2025 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [•], 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Li-Cycle Holdings Corp., an Ontario corporation (the “Company”), up to [•] Common Shares (subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT POET Technologies Inc.
Common Share Purchase Warrant • December 4th, 2024 • Poet Technologies Inc. • Semiconductors & related devices • New York

THIS COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 2, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from POET Technologies Inc., a corporation existing under laws of the Province of Ontario, Canada (the “Company”), up to 2,777,778 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT APTOSE BIOSCIENCES INC.
Common Share Purchase Warrant • November 25th, 2024 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aptose Biosciences Inc., a Canadian corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares, no par value per share (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT Lineage Cell Therapeutics, Inc.
Common Share Purchase Warrant • November 20th, 2024 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 21, 2025 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) the three (3) year anniversary of the Initial Exercise Date, and (ii) the 90th day following the date of the public disclosure of the occurrence of the Milestone Event subject to the satisfaction of the Equity Conditions (as defined below), or if the date of the public disclosure of the occurrence of the Milestone Event occurs prior to the Initial Exercise Date, the 90th day following the Initial Exercise Date, subject to the satisfaction of the Equity Conditions (the “Termination Date”), but not thereafter, to subscribe for and purchase from Lineage Cell Therapeutics, Inc., a California corporation (the “Comp

COMMON SHARE PURCHASE WARRANT Lineage Cell Therapeutics, Inc.
Common Share Purchase Warrant • November 20th, 2024 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and conditions hereinafter set forth, at any time on or after the later of (a) Stockholder Approval Date and (b) the six month anniversary of the First Closing Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) the three (3) year anniversary of the Initial Exercise Date, and (ii) the 90th day following the date of the public disclosure of the occurrence of the Milestone Event, subject to the satisfaction of the Equity Conditions (as defined below) or if the date of the public disclosure of the occurrence of the Milestone Event occurs prior to the Initial Exercise Date, the 90th day following the Initial Exercise Date, subject to the satisfaction of the Equity Conditions (the “Termination Date”), but not thereafter, to subscribe for and purchase from Lineage Cell Therapeutics

COMMON SHARE PURCHASE WARRANT DAMON INC.
Common Share Purchase Warrant • November 18th, 2024 • Damon Inc. • Services-computer programming services • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is [five (5) years] after the Initial Exercise Date (such applicable date, the “Termination Date”) but not thereafter, to subscribe for and purchase from Damon Inc., a British Columbia company (the “Company”), up to [_________] common shares in the authorized share structure of the Company (“Common Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT APTOSE BIOSCIENCES INC.
Common Share Purchase Warrant • October 31st, 2024 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances)

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aptose Biosciences Inc., a Canadian corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares, no par value per share (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT XORTX THERAPEUTICS INC.
Common Share Purchase Warrant • October 18th, 2024 • XORTX Therapeutics Inc. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the fifth (5th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from XORTX Therapeutics Inc., a British Columbia corporation (the “Company”), up to [ ] common shares of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT NLS PHARMACEUTICS LTD.
Common Share Purchase Warrant • October 11th, 2024 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT, issued in the form of uncertificated securities (Wertrechte) pursuant to article 973c of the Swiss Code of Obligations (the “Warrant”), certifies that, for value received, [_______________], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October [*], 2029 (the “Termination Date”) but not thereafter, to subscribe for and/or purchase from NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”), up to [________] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Company may issue the Warrant Shares from its Treasury Shares and/or conditional

COMMON SHARE PURCHASE WARRANT LeddarTech Holdings Inc.
Common Share Purchase Warrant • August 19th, 2024 • LeddarTech Holdings Inc. • Services-prepackaged software • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from LeddarTech Holdings Inc., a company incorporated under the laws of Canada (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s

COMMON SHARE PURCHASE WARRANT POET Technologies Inc.
Common Share Purchase Warrant • July 19th, 2024 • Poet Technologies Inc. • Semiconductors & related devices • New York

THIS COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 18, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from POET Technologies Inc., a corporation existing under laws of the Province of Ontario, Canada (the “Company”), up to 3,333,334 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT MEDICUS PHARMA LTD.
Common Share Purchase Warrant • July 15th, 2024 • Medicus Pharma Ltd. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Medicus Pharma Ltd., a corporation organized under the laws of Ontario, Canada (the "Company"), up to ______ common shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, s

COMMON SHARE PURCHASE WARRANT
Common Share Purchase Warrant • July 2nd, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Platinum Point Capital LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 4, 2024 (as defined in the Purchase Agreement) has been received (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of such Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mangoceuticals, Inc., a corporation incorporated under the laws of the State of Texas (the “Company”), up to 500,000 (as subject to adjustment hereunder, the “Warrant Shares”) Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT
Common Share Purchase Warrant • July 2nd, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Platinum Point Capital LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 4, 2024 (as defined in the Purchase Agreement) has been received (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of such Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mangoceuticals, Inc., a corporation incorporated under the laws of the State of Texas (the “Company”), up to 1,000,000 (as subject to adjustment hereunder, the “Warrant Shares”) Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT NLS PHARMACEUTICS LTD.
Common Share Purchase Warrant • July 1st, 2024 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT, issued in the form of uncertificated securities (Wertrechte) pursuant to article 973c of the Swiss Code of Obligations (the “Warrant”), certifies that, for value received, [_______________], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 2, 2029 (the “Termination Date”) but not thereafter, to subscribe for and/or purchase from NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”), up to [________] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Company may issue the Warrant Shares from its Treasury Shares and/or conditional capi

SERIES A/SERIES B] COMMON SHARE PURCHASE WARRANT APTOSE BIOSCIENCES INC.
Common Share Purchase Warrant • June 3rd, 2024 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances)

THIS [SERIES A/SERIES B] COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Shareholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the [Series A: five (5) year anniversary of the Initial Exercise Date/Series B: eighteen (18) months anniversary of the Initial Exercise Date], provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”), but not thereafter, to subscribe for and purchase from Aptose Biosciences Inc., a corporation organized under the laws of Canada (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares. The purchase price of one Common Share under this

COMMON SHARE PURCHASE WARRANT BriaCell Therapeutics Corp.
Common Share Purchase Warrant • May 17th, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 17, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 17, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT
Common Share Purchase Warrant • May 14th, 2024 • 1847 Holdings LLC • Services-management consulting services

This COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, SPARTAN CAPITAL SECURITIES, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is the six-months (the “Initial Exercise Date”) after the Initial Issue Date set forth hereinabove (the “Initial Issue Date”) and until the earlier of the fifth anniversary of the Initial Issue Date and the date that this Warrant is exercised in full (as the case may be, the “Termination Date”) but not thereafter, to subscribe for and purchase from 1847 Holdings LLC, a limited liability company formed under the laws of the State of Delaware (the “Company”), up to the Initial Number of Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the common shares, no par value, of the Company (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be eq

COMMON SHARE PURCHASE WARRANT
Common Share Purchase Warrant • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Platinum Point Capital LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 4, 2024 (as defined in the Purchase Agreement) has been received (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of such Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mangoceuticals, Inc., a corporation incorporated under the laws of the State of Texas (the “Company”), up to 3,300,000 (as subject to adjustment hereunder, the “Warrant Shares”) Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT VBI VACCINES INC.
Common Share Purchase Warrant • April 11th, 2024 • VBI Vaccines Inc/Bc • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 11, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from VBI VACCINES INC., a company organized under the laws of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT NLS PHARMACEUTICS LTD.
Common Share Purchase Warrant • March 21st, 2024 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT, issued in the form of uncertificated securities (Wertrechte) pursuant to article 973c of the Swiss Code of Obligations (the “Warrant”), certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 22, 2029 (the “Termination Date”) but not thereafter, to subscribe for and/or purchase from NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland (the “Company”), up to [____] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Company may issue the Warrant Shares from its Treasury Shares and/or conditional capital f

COMMON SHARE PURCHASE WARRANT PRETAM HOLDINGS INC.
Common Share Purchase Warrant • January 25th, 2024 • PreTam Holdings Inc. • Concrete products, except block & brick • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20__1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PreTam Holdings Inc., a company incorporated under the laws of Alberta, Canada (the “Company”), up to [___] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant,

COMMON SHARE PURCHASE WARRANT PRETAM HOLDINGS INC.
Common Share Purchase Warrant • December 22nd, 2023 • PreTam Holdings Inc. • Concrete products, except block & brick • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20__1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PreTam Holdings Inc., a company incorporated under the laws of Alberta, Canada (the “Company”), up to [___] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant,

COMMON SHARE PURCHASE WARRANT POET Technologies Inc.
Common Share Purchase Warrant • December 4th, 2023 • Poet Technologies Inc. • Semiconductors & related devices • New York

THIS COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______ (the “Termination Date”) but not thereafter, to subscribe for and purchase from POET Technologies Inc., a corporation existing under laws of the Province of Ontario, Canada (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT NEPTUNE WELLNESS SOLUTIONS INC.
Common Share Purchase Warrant • September 27th, 2023 • Neptune Wellness Solutions Inc. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September __, 2028 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Neptune Wellness Solutions Inc., a company incorporated under the law of the Province of Quebec (the “Company”), up to [______] common shares, without par value (the “Common Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant is one of the Warrants to purchase Common Shares (the “Warrants”) issued pursuant to the Purchase Agreement (as defined below).

COMMON SHARE PURCHASE WARRANT NEPTUNE WELLNESS SOLUTIONS INC.
Common Share Purchase Warrant • September 15th, 2023 • Neptune Wellness Solutions Inc. • Pharmaceutical preparations • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 15, 2028 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Neptune Wellness Solutions Inc., a company incorporated under the law of the Province of Quebec (the “Company”), up to [______] common shares, without par value (the “Common Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant is one of the Warrants to purchase Common Shares (the “Warrants”) issued pursuant to the Purchase Agreement (as defined below).

COMMON SHARE PURCHASE WARRANT Bruush Oral Care Inc.
Common Share Purchase Warrant • August 23rd, 2023 • Bruush Oral Care Inc. • Dental equipment & supplies • New York

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 9, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bruush Oral Care Inc., a corporation incorporated under the law of the Province of British Columbia, Canada (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT
Common Share Purchase Warrant • August 14th, 2023 • 1847 Holdings LLC • Services-management consulting services

This COMMON SHARE PURCHASE WARRANT (this “Warrant”) certifies that, for value received, SPARTAN CAPITAL SECURITIES, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is the six-months (the “Initial Exercise Date”) after the Initial Issue Date set forth hereinabove (the “Initial Issue Date”) and until the earlier of the fifth anniversary of the Initial Issue Date and the date that this Warrant is exercised in full (as the case may be, the “Termination Date”) but not thereafter, to subscribe for and purchase from 1847 Holdings LLC, a limited liability company formed under the laws of the State of Delaware (the “Company”), up to the Initial Number of Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the common shares, no par value, of the Company (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be eq